Maki Inoue-Choi
Cancer Epidemiologist | RWE | Pharmacoepidemiology | Oncology Outcomes Research | Medical Affairs
- Role
- Associate Director, Oncology Outcomes Research, Global Medical Affairs at AstraZeneca
- Location
- Washington, DC, US
- LinkedIn followers
- 500 followers
About Maki Inoue-Choi
Accomplished epidemiologist with 18+ years of experience driving evidence strategies in…
Experience
Associate Director, Oncology Outcomes Research, Global Medical Affairs
Nov 2023 — Present · Gaithersburg, MD, US
Asset Strategy Development: Spearheaded the development and execution of asset strategies, including RWE activities, to assess, quantify, and effectively communicate the clinical benefits of Enhertu in the breast cancer treatment landscape.• RWE Study Leadership: Led the execution of RWE studies, which involved developing study concepts and protocols, and collaborating with data analysts and contract research organizations (CROs) to ensure timely and accurate analyses.• Strategic Communication: Effectively communicated and influenced a diverse group of internal and external stakeholders, including alliance partners and key external experts (KEEs), to ensure alignment and maintain strategic focus.• Governance and Review Support: Supported internal review and governance meetings, ensuring the scientific rigor and integrity of AstraZeneca-sponsored research, including Evidence Review Team (ERT).• CRO and Budget Management: Successfully managed relationships and budgets with CROs to guarantee the timely completion of high-quality projects.
Education
Waseda University
Bachelor of Arts (B.A.)
University of Minnesota-Twin Cities
Doctor of Philosophy (PhD)
University of Washington
Master of Science (MS)
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.